Abound Wealth Management’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-24
Closed -$2.41K 1535
2025
Q4
$2.41K Hold
24
﹤0.01% 818
2025
Q3
$1.3K Hold
24
﹤0.01% 849
2025
Q2
$1.26K Buy
+24
New +$1.22K ﹤0.01% 784
2025
Q1
Sell
-2
Closed -$94 1292
2024
Q4
$94 Buy
+2
New +$124 ﹤0.01% 1210
2023
Q4
Sell
-24
Closed -$1.62K 1376
2023
Q3
$1.62K Hold
24
﹤0.01% 639
2023
Q2
$2.23K Hold
24
﹤0.01% 634
2023
Q1
$1.61K Hold
24
﹤0.01% 607
2022
Q4
$1.18K Hold
24
﹤0.01% 600
2022
Q3
$774 Buy
+24
New +$989 ﹤0.01% 629

Other funds holding EXAS

Abound Wealth Management's EXAS Position: Q1 2026 in Review

Abound Wealth Management sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 24 shares — an estimated $2.41K sold.

Abound Wealth Management first reported a position in EXAS in Q3 2022 and held it in 9 quarters. The position peaked at $2.41K in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Abound Wealth Management reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Abound Wealth Management sold 24 Exact Sciences shares in Q1 2026, an estimated $2.41K.
  • Abound Wealth Management first reported a position in Exact Sciences in Q3 2022 and held it in 9 quarters.
  • Abound Wealth Management's Exact Sciences position peaked at $2.41K in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Abound Wealth Management's 13F filing for Q1 2026, filed 10 Apr 2026.